This live web event has ended. Thank you for attending.
**This is a recording of the live webinar on March 11, 2021**
This webinar will alert epilepsy providers about new FDA safety warnings regarding potential cardiac effects of lamotrigine and to offer guidance for clinical care and communicating with patients.
Faculty will share their expertise in pharmacology, cardiology and epilepsy clinical care in the context of guidance on the lamotrigine safety warning. The webinar agenda includes time for attendee Q&A and input about the impact of lamotrigine in clinical practice.